NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,931,645 | +1045.2% | 48,747 | +4120.5% | 0.01% | +1300.0% |
| Q2 2021 | $256,000 | -97.9% | 1,155 | -98.8% | 0.00% | -96.7% |
| Q1 2021 | $12,275,000 | -67.2% | 92,866 | -57.1% | 0.03% | -61.0% |
| Q4 2020 | $37,446,000 | -28.9% | 216,400 | -54.3% | 0.08% | -40.8% |
| Q3 2020 | $52,694,000 | +514.5% | 473,400 | +227.4% | 0.13% | +333.3% |
| Q2 2020 | $8,575,000 | +65.4% | 144,602 | +87.9% | 0.03% | -3.2% |
| Q1 2020 | $5,184,000 | -40.7% | 76,970 | -25.8% | 0.03% | -31.1% |
| Q4 2019 | $8,747,000 | +1883.4% | 103,799 | +1659.3% | 0.04% | +1400.0% |
| Q3 2019 | $441,000 | -62.1% | 5,900 | -73.4% | 0.00% | -40.0% |
| Q3 2018 | $1,163,000 | – | 22,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |